Annual Drug Patent Expirations for CLARINEX+D+24+HOUR Clarinex D 24 Hour is a drug marketed by Organon and is included in one NDA. There are two patents protecting this drug. This…
The post New patent expiration for Organon drug CLARINEX D 24 HOUR appe…
New patent expiration for Organon drug CLARINEX D 24 HOUR Read Post »
Annual Drug Patent Expirations for MYRBETRIQ+GRANULES Myrbetriq Granules is a drug marketed by Apgdi and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for APGDI drug MYRBETRIQ GRANULES…
New patent expiration for APGDI drug MYRBETRIQ GRANULES Read Post »
Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are eight patents protecting…
The post New patent expiration for APGDI drug MYRBETRIQ appeared f…
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It is available from one supplier.…
The post New patent expiration for Otsuka drug ABILIFY appeared first on DrugPatent…
Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.…
The post New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA…
New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA KIT Read Post »
Annual Drug Patent Expirations for BETHKIS Bethkis is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent expiration for Chiesi drug BETHKIS appeared first on…
BETHKIS (tobramycin) Chiesi Patent: 6,987,094 Expiration: Sep 22, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Paten…
Drug Patent Expirations for the Week of September 18, 2022 Read Post »
Annual Drug Patent Expirations for VAGIFEM Vagifem is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Novo Nordisk drug VAGIFEM appeared first on DrugPa…
New patent expiration for Novo Nordisk drug VAGIFEM Read Post »
BREO ELLIPTA (fluticasone furoate; vilanterol trifenatate) Glaxo grp ltd Patent: 7,776,895 Expiration: Sep 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
The post Drug Patent Expirations for …
Drug Patent Expirations for the Week of September 11, 2022 Read Post »
Annual Drug Patent Expirations for CIPRODEX Ciprodex is a drug marketed by Novartis and is included in one NDA. It is available from three suppliers. There are four patents protecting…
The post New patent expiration for Novartis drug CIPRODEX appeared …
New patent expiration for Novartis drug CIPRODEX Read Post »